相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers
Hong-Beom Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2022)
Bidirectional Role of NLRP3 During Acute and Chronic Cholestatic Liver Injury
Mick Frissen et al.
HEPATOLOGY (2021)
In vitro inhibition and induction of human liver cytochrome P450 enzymes by a novel anti-fibrotic drug fluorofenidone
Linling Li et al.
XENOBIOTICA (2021)
Effect of Fluorofenidone Against Paraquat-Induced Pulmonary Fibrosis Based on Metabolomics and Network Pharmacology
Feiya Jiang et al.
MEDICAL SCIENCE MONITOR (2021)
Protective Effect of Fluorofenidone Against Acute Lung Injury Through Suppressing the MAPK/NF-κB Pathway
Xin Lv et al.
FRONTIERS IN PHARMACOLOGY (2021)
A novel role for interleukin 32 in cholestasis
Xiaoxun Zhang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Liver cirrhosis
Pere Gines et al.
LANCET (2021)
Adipose Stromal Cell-Secretome Counteracts Profibrotic Signals From IPF Lung Matrices
Gwenda F. Vasse et al.
FRONTIERS IN PHARMACOLOGY (2021)
Cholestatic Liver Diseases: A Primer for Generalists and Subspecialists
Moira B. Hilscher et al.
MAYO CLINIC PROCEEDINGS (2020)
Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway
Qin Dai et al.
FRONTIERS IN PHARMACOLOGY (2020)
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Immunological abnormalities in patients with primary biliary cholangitis
Wen-Tao Ma et al.
CLINICAL SCIENCE (2019)
Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice
Li Wen-Kai et al.
PHYTOMEDICINE (2019)
Fluorofenidone inhibits apoptosis of renal tubular epithelial cells in rats with renal interstitial fibrosis
Hui Yang et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2019)
Animal models of biliary injury and altered bile acid metabolism
Valeria Mariotti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Primary biliary cholangitis: Old and novel therapy
Annarosa Floreani et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
A guide to chemokines and their receptors
Catherine E. Hughes et al.
FEBS JOURNAL (2018)
Primary sclerosing cholangitis
Jessica K. Dyson et al.
LANCET (2018)
Fluorofenidone attenuates interleukin-1 production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction
Linfeng Zheng et al.
NEPHROLOGY (2018)
Idiopathic Pulmonary Fibrosis
David J. Lederer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effects of pirfenidone in acute and sub-chronic liver fibrosis, and an initiation-promotion cancer model in the mouse
Oleksii Seniutkin et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Pivotal roles of Kupffer cells in the progression and regression of DDC-induced chronic cholangiopathy
Leila Jemail et al.
SCIENTIFIC REPORTS (2018)
Nuclear Receptor Metabolism of Bile Acids and Xenobiotics: A Coordinated Detoxification System with Impact on Health and Diseases
Manon Garcia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The Ascending Pathophysiology of Cholestatic Liver Disease
Peter L. M. Jansen et al.
HEPATOLOGY (2017)
Targeting hepatic macrophages to treat liver diseases
Frank Tacke
JOURNAL OF HEPATOLOGY (2017)
Mechanisms of bile acid mediated inflammation in the liver
Man Li et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response
Shi-Ying Cai et al.
JCI INSIGHT (2017)
Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis
Haiping Hao et al.
CELL METABOLISM (2017)
Novel Therapies on Primary Biliary Cirrhosis
Frank Czul et al.
CLINICS IN LIVER DISEASE (2016)
Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1/IL-1R1/MyD88/NF-B pathway
Cheng Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
The Protective Mechanism of Fluorofenidone in Renal Interstitial Inflammation and Fibrosis
Yiting Tang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2015)
Pathological implications of cadherin zonation in mouse liver
Madlen Hempel et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways
Ekihiro Seki et al.
HEPATOLOGY (2015)
Fluorofenidone inhibits macrophage IL-1β production by suppressing inflammasome activity
Miaomiao Lu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
FLUOROFENIDONE ATTENUATES TGF-β1-INDUCED LUNG FIBROBLAST ACTIVATION VIA RESTORING THE EXPRESSION OF CAVEOLIN-1
Jingjing Liu et al.
SHOCK (2015)
Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells
Yu Peng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Prospective Evaluation of Ursodeoxycholic Acid Withdrawal in Patients With Primary Sclerosing Cholangitis
Ewa Wunsch et al.
HEPATOLOGY (2014)
Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways
Xuan Xiong et al.
PLOS ONE (2014)
IL-17A Synergistically Enhances Bile Acid-Induced Inflammation during Obstructive Cholestasis
Kate M. O'Brien et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management
John E. Eaton et al.
GASTROENTEROLOGY (2013)
Early Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis of Primary Biliary Cirrhosis: Results of a 14-Year Cohort Study
Li-Na Zhang et al.
HEPATOLOGY (2013)
Contrasting responses of Kupffer cells and inflammatory mononuclear phagocytes to biliary obstruction in a mouse model of cholestatic liver injury
Caroline C. Duwaerts et al.
LIVER INTERNATIONAL (2013)
Design, Synthesis and Antifibrotic Activities of Carbohydrate-Modified 1-(Substituted aryl)-5-trifluoromethyl-2(1H) Pyridones
Qinghua Lou et al.
MOLECULES (2012)
In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences
Hiroshi Komura et al.
DRUG METABOLISM REVIEWS (2011)
Fluorofenidone Attenuates Diabetic Nephropathy and Kidney Fibrosis in db/db Mice
Ling Hao Wang et al.
PHARMACOLOGY (2011)
Gender Dimorphic Formation of Mouse Mallory-Denk Bodies and the Role of Xenobiotic Metabolism and Oxidative Stress
Shinichiro Hanada et al.
GASTROENTEROLOGY (2010)
Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling
Katryn Allen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Primary biliary cirrhosis
Simon Hohenester et al.
SEMINARS IN IMMUNOPATHOLOGY (2009)
Medical Treatment of Cholestatic Liver Disease
Gustav Paumgartner et al.
CLINICS IN LIVER DISEASE (2008)
A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis
Peter Fickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine
M Martignoni et al.
DRUG METABOLISM AND DISPOSITION (2006)
Early growth response factor-1 is critical for cholestatic liver injury
ND Kim et al.
TOXICOLOGICAL SCIENCES (2006)
Pirfenidone effectively reverses experimental liver fibrosis
L García et al.
JOURNAL OF HEPATOLOGY (2002)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
分享论文
